These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 9284199

  • 21. 1,25-dihydroxyvitamin D3 and the synthetic vitamin D analogue, KH 1060, modulate the growth of mouse proximal tubular cells.
    Weinreich T, Müller A, Wüthrich RP, Booy C, Binswanger U.
    Kidney Blood Press Res; 1996; 19(6):325-31. PubMed ID: 8990044
    [Abstract] [Full Text] [Related]

  • 22. Inhibition of insulin- and insulin-like growth factor-I-stimulated growth of human breast cancer cells by 1,25-dihydroxyvitamin D3 and the vitamin D3 analogue EB1089.
    Vink-van Wijngaarden T, Pols HA, Buurman CJ, Birkenhäger JC, van Leeuwen JP.
    Eur J Cancer; 1996 May; 32A(5):842-8. PubMed ID: 9081364
    [Abstract] [Full Text] [Related]

  • 23. Vitamin D receptors and anti-proliferative effects of vitamin D derivatives in human pancreatic carcinoma cells in vivo and in vitro.
    Colston KW, James SY, Ofori-Kuragu EA, Binderup L, Grant AG.
    Br J Cancer; 1997 May; 76(8):1017-20. PubMed ID: 9376260
    [Abstract] [Full Text] [Related]

  • 24. A calcitriol analogue, EB1089, inhibits the growth of LNCaP tumors in nude mice.
    Blutt SE, Polek TC, Stewart LV, Kattan MW, Weigel NL.
    Cancer Res; 2000 Feb 15; 60(4):779-82. PubMed ID: 10706079
    [Abstract] [Full Text] [Related]

  • 25. Synergistic inhibition of prostate cancer cell lines by a 19-nor hexafluoride vitamin D3 analogue and anti-activator protein 1 retinoid.
    Campbell MJ, Park S, Uskokovic MR, Dawson MI, Jong L, Koeffler HP.
    Br J Cancer; 1999 Jan 15; 79(1):101-7. PubMed ID: 10408700
    [Abstract] [Full Text] [Related]

  • 26. Vitamin D-induced up-regulation of tumour necrosis factor alpha (TNF-alpha) in prostate cancer cells.
    Golovko O, Nazarova N, Tuohimaa P.
    Life Sci; 2005 Jun 17; 77(5):562-77. PubMed ID: 15904673
    [Abstract] [Full Text] [Related]

  • 27. Growth inhibitory effects of 1,25-dihydroxyvitamin D3 and its synthetic analogue, 1alpha,25-dihydroxy-16-ene-23yne-26,27-hexafluoro-19-nor-cholecalcifero l (Ro 25-6760), on a human colon cancer xenograft.
    Evans SR, Schwartz AM, Shchepotin EI, Uskokovic M, Shchepotin IB.
    Clin Cancer Res; 1998 Nov 17; 4(11):2869-76. PubMed ID: 9829754
    [Abstract] [Full Text] [Related]

  • 28. Role of 24-hydroxylase in vitamin D3 growth response of OVCAR-3 ovarian cancer cells.
    Miettinen S, Ahonen MH, Lou YR, Manninen T, Tuohimaa P, Syvälä H, Ylikomi T.
    Int J Cancer; 2004 Jan 20; 108(3):367-73. PubMed ID: 14648702
    [Abstract] [Full Text] [Related]

  • 29. 1Alpha,25dihydroxyvitamin D3 and platinum drugs act synergistically to inhibit the growth of prostate cancer cell lines.
    Moffatt KA, Johannes WU, Miller GJ.
    Clin Cancer Res; 1999 Mar 20; 5(3):695-703. PubMed ID: 10100724
    [Abstract] [Full Text] [Related]

  • 30. Vitamin D receptor is expressed in pancreatic cancer cells and a vitamin D3 analogue decreases cell number.
    Albrechtsson E, Jonsson T, Möller S, Höglund M, Ohlsson B, Axelson J.
    Pancreatology; 2003 Mar 20; 3(1):41-6. PubMed ID: 12649563
    [Abstract] [Full Text] [Related]

  • 31. The vitamin D analogue EB 1089 prevents skeletal metastasis and prolongs survival time in nude mice transplanted with human breast cancer cells.
    El Abdaimi K, Dion N, Papavasiliou V, Cardinal PE, Binderup L, Goltzman D, Ste-Marie LG, Kremer R.
    Cancer Res; 2000 Aug 15; 60(16):4412-8. PubMed ID: 10969786
    [Abstract] [Full Text] [Related]

  • 32. Three synthetic vitamin D analogues induce prostate-specific acid phosphatase and prostate-specific antigen while inhibiting the growth of human prostate cancer cells in a vitamin D receptor-dependent fashion.
    Hedlund TE, Moffatt KA, Uskokovic MR, Miller GJ.
    Clin Cancer Res; 1997 Aug 15; 3(8):1331-8. PubMed ID: 9815816
    [Abstract] [Full Text] [Related]

  • 33. EB1089: a new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro.
    Colston KW, Mackay AG, James SY, Binderup L, Chander S, Coombes RC.
    Biochem Pharmacol; 1992 Dec 15; 44(12):2273-80. PubMed ID: 1472092
    [Abstract] [Full Text] [Related]

  • 34. Effect of a vitamin D3 analogue on keratinocyte growth factor-induced cell proliferation in benign prostate hyperplasia.
    Crescioli C, Maggie M, Vannelli GB, Luconi M, Salerno R, Barni T, Gulisano M, Forti G, Serio M.
    J Clin Endocrinol Metab; 2000 Jul 15; 85(7):2576-83. PubMed ID: 10902811
    [Abstract] [Full Text] [Related]

  • 35. Vitamin D3 analogs inhibit growth and induce differentiation in LA-N-5 human neuroblastoma cells.
    Moore TB, Koeffler HP, Yamashiro JM, Wada RK.
    Clin Exp Metastasis; 1996 May 15; 14(3):239-45. PubMed ID: 8674278
    [Abstract] [Full Text] [Related]

  • 36. 1alpha,25-Dihydroxyvitamin D3-3beta-(2)-bromoacetate, an affinity labeling derivative of 1alpha,25-dihydroxyvitamin D3 displays strong antiproliferative and cytotoxic behavior in prostate cancer cells.
    Swamy N, Persons KS, Chen TC, Ray R.
    J Cell Biochem; 2003 Aug 01; 89(5):909-16. PubMed ID: 12874825
    [Abstract] [Full Text] [Related]

  • 37. A novel cytostatic form of autophagy in sensitization of non-small cell lung cancer cells to radiation by vitamin D and the vitamin D analog, EB 1089.
    Sharma K, Goehe RW, Di X, Hicks MA, Torti SV, Torti FM, Harada H, Gewirtz DA.
    Autophagy; 2014 Aug 01; 10(12):2346-61. PubMed ID: 25629933
    [Abstract] [Full Text] [Related]

  • 38. Growth inhibitory effects on human colon adenocarcinoma-derived Caco-2 cells and calcemic potential of 1 alpha,25-dihydroxyvitamin D3 analogs: structure-function relationships.
    Bischof MG, Redlich K, Schiller C, Chirayath MV, Uskokovic M, Peterlik M, Cross HS.
    J Pharmacol Exp Ther; 1995 Dec 01; 275(3):1254-60. PubMed ID: 8531089
    [Abstract] [Full Text] [Related]

  • 39. A novel vitamin D analog with two double bonds in its side chain. A potent inducer of osteoblastic cell differentiation.
    Mahonen A, Jääskeläinen T, Mäenpää PH.
    Biochem Pharmacol; 1996 Apr 12; 51(7):887-92. PubMed ID: 8651937
    [Abstract] [Full Text] [Related]

  • 40. Growth of methionine-dependent human prostate cancer (PC-3) is inhibited by ethionine combined with methionine starvation.
    Poirson-Bichat F, Gonfalone G, Bras-Gonçalves RA, Dutrillaux B, Poupon MF.
    Br J Cancer; 1997 Apr 12; 75(11):1605-12. PubMed ID: 9184175
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.